Khiron Life Sciences Corp.

Equities

KHRN.H

CA49374L3065

Pharmaceuticals

Delayed Toronto S.E. 10:54:46 2023-05-05 am EDT 5-day change 1st Jan Change
0.04 CAD -.--% Intraday chart for Khiron Life Sciences Corp. -.--% -.--%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Colombia's cannabis industry in crisis over regulatory, political hurdles RE
2518542 Alberta Ltd completed the acquisition of Khiron Europe Gmbh, Zerenia Clinics Limited, Khiron Life Sciences Spain SL, Khiron Life Sciences Uk and Pharmadrug Production GmbH from Khiron Life Sciences Corp.. CI
2518542 Alberta Ltd agreed to acquire Khiron Europe Gmbh, Zerenia Clinics Limited, Khiron Life Sciences Spain SL, Khiron Life Sciences Uk and Pharmadrug Production GmbH from Khiron Life Sciences Corp. for CAD 3 million. CI
Khiron Life Sciences Corp. Enters into Partnership with an Accredited 3rd Party Contract Manufacturing Organization CI
Khiron Life Sciences Brief: On Filing of Audited Annual Financial Statements, Co Says Won't Make It On Or Before the Prescribed Deadline of May 1, 2023, as a Result of the Change in CFO MT
Khiron Life Sciences Brief: Appointing Michael O'Connor as Chief Financial Officer, Replacing Ms. Helen Bellwood MT
Khiron Life Sciences Announces CFO Changes CI
Toronto Stocks Climb; TerrAscend Rises on Plans to Apply for TSX Listing DJ
Khiron Life Sciences Plans Overnight Marketed Offering of Share Units MT
Khiron Life Sciences Secures Additional Loan with Investment-Grade Bank MT
Khiron Life Sciences Corp. Announces That Its Wholly Owned Subsidiary Zerenia Colombia Closes an Unsecured Revolving Credit Facility of CAD 580,000 with Private Financing Company in Colombia CI
Khiron Life Sciences Starts Providing Insurance-covered Prescriptions in Colombia MT
Khiron Edging Up as Notes NHS Reimburses Cost of Cannabis Treatment to First Zerenia Clinics UK Patient MT
Khiron Life Sciences Corp. Announces Full Reimbursement by the NHS of Costs Associated to Cannabis-Based Medication and Clinic Fees for A Patient Enrolled in Zerenia Clinics UK CI
Khiron Wins First Medical Cannabis Contract with Colombia's Largest Public Insurance Company CI
Khiron Up 41% As Notes Government of Colombia Declares Mandatory Insurance Coverage for Medical Cannabis Products MT
Transcript : Khiron Life Sciences Corp., Q3 2022 Earnings Call, Nov 30, 2022
Khiron Life Sciences Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Khiron Begins Sales in Switzerland, Increases Offerings in Germany, UK MT
Khiron Life Sciences Corp. Begins Sales in Switzerland and Expands Its Medical Cannabis Portfolio in Germany and the United Kingdom CI
Khiron Life Sciences Awarded Best Latin American Cannabis Company at Benzinga Cannabis Capital Conference MT
Khiron Life Sciences Corp.'s Equity Buyback announced on September 9, 2021 has expired. CI
Khiron Life Sciences Up 4% after Reporting Launch of New Cannabis Products in Europe MT
Khiron Launches New Cannabis Products in Europe Including Stellar Genetics from California CI
Transcript : Khiron Life Sciences Corp., Q2 2022 Earnings Call, Aug 29, 2022
Chart Khiron Life Sciences Corp.
More charts
Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line, the Company is focused on product sales in Latin America. The Company operates its own network of health centers (operating under the Zerenia brand) and Zerenia satellite clinics offering a suite of health, medical and surgical services, in alignment with both insurance company partners and private practice. Its subsidiaries include Khiron Life Sciences Corp. (Canada), Khiron Colombia S.A.S., Zerenia S.A.S., NettaGrowth International Inc., and others.
More about the company

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Khiron Life Sciences Corp. - Toronto S.E.
  4. News Khiron Life Sciences Corp.
  5. Khiron Life Sciences : Medical Reports Cannabis Products Arrive in Germany For Immediate Prescription, Sale and Distribution